Myths vs facts: APOA2 and Wechseljahre

The APOA2 gene encodes apolipoprotein A-II, a component of HDL metabolism. During menopause, declining estrogen alters lipid profiles, often raising LDL and changing HDL. Some studies suggest that APOA2 variants may modestly influence weight gain or lipid changes in menopause, but the evidence is weak and inconsistent. Direct-to-consumer tests like MyBody-X analyze APOA2, but results are not diagnostic and lack clinical validation for menopause management. Fact: Lifestyle factors (diet, exercise) have a far greater impact on cardiovascular risk during menopause than single gene variants. Myth: APOA2 determines whether you will gain weight in menopause – this is not supported by strong evidence. Genetics provide only a small piece of the puzzle; hormone status, age, and lifestyle are key. Beware of exaggerated marketing claims.